IMMUNOGEN INC·4

Jun 15, 10:00 AM ET

IMMUNOGEN INC 4

4 · IMMUNOGEN INC · Filed Jun 15, 2017

Insider Transaction Report

Form 4
Period: 2017-06-13
Transactions
  • Award

    Stock option (right to buy)

    2017-06-13$4.64/sh+10,000$46,40010,000 total
    Exercise: $4.64From: 2017-09-01Exp: 2027-06-13Common Stock (10,000 underlying)
  • Award

    Deferred Share Unit

    2017-06-13+3,00089,845 total
    Exercise: $0.00From: 2017-09-01Common Stock (3,000 underlying)
Footnotes (4)
  • [F1]The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
  • [F2]The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
  • [F3]The deferred share units vest quarterly on 9/1/17, 12/1/17, 3/1/18 and 6/1/18, contingent upon the individual remaining a director as of each vesting date.
  • [F4]Exercisable as to 2,500 shares on 9/1/17, 12/1/17, 3/1/18 and 6/1/18, contingent upon the individual remaining a director as of each vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -